Doxorubicin Completed Phase 1 Trials for Fallopian Tube Cancer / Recurrent Ovarian Epithelial Cancer / Peritoneal Cavity Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02260544Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
NCT01281514A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer